Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in research, development, manufacturing and marketing of biopharmaceutical products

3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.

It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.

The company was founded by Jing Lou and Dan Lou in 1993 and is headquartered in Shenyang, China.
Managers
NameAgeSinceTitle
Jing Lou MD, PhD541993Chairman, President & Chief Executive Officer
Wei hong Xiao-2016Chief Operating Officer
Bo Tan, MBA442009Chief Financial Officer & Executive Director
Zhenping Zhu MD, PhD-2017Chief Scientific Officer, President-R&D
Dong Mei Su, PhD462012Executive Director
Bin Huang, MBA561993Executive Director & Vice President
Dong Liu, MBA442014Non-Executive Director
Dong Lü, PhD422014Non-Executive Director
Tian Ruo Pu, MBA482014Independent Non-Executive Director
David R. Parkinson MD, PhD652014Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,532,313,570 969,706,150 38.3% 0 0.0% 38.3%
Shareholders
NameEquities%
CITIC Private Equity Funds Management Co., Ltd. 712,258,360 28.1%
Jing Lou, MD, PhD 599,367,030 23.7%
Bo Tan, MBA 116,849,920 4.61%
Dan Lou 62,001,010 2.45%
HSBC Global Asset Management (Hong Kong) Ltd. 38,265,854 1.51%
OppenheimerFunds, Inc. 34,846,000 1.38%
Bin Huang, MBA 32,197,350 1.27%
The Vanguard Group, Inc. 29,247,500 1.16%
Dong Mei Su, PhD 25,445,630 1.00%
BlackRock Fund Advisors 20,978,000 0.83%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
3SBIO INC. (ADR)0.00%2 946
BIOGEN INC8.96%61 574
CSL LIMITED19.50%41 358
ALEXION PHARMACEUTICAL..6.61%29 546
BIOMARIN PHARMACEUTICA..7.79%15 051
GRIFOLS SA11.89%13 922
3SBIO INC18.82%2 946
JIANGXI BOYA BIO-PHARM..--.--%2 366
ABCAM PLC10.43%2 149
PROMETIC LIFE SCIENCES..-1.32%1 072
HUGEL INC--.--%1 011
BIOTEST AG23.87%745
ANIKA THERAPEUTICS INC1.25%728
PHARMA MAR SA2.21%649
MEDIWOUND LTD31.03%128
VIVUS, INC.1.74%120
CARDIOME PHARMA CORP0.00%96
VERICEL CORP-1.67%93
ALIMERA SCIENCES INC13.89%82
CO DON AG36.02%69
STEADYMED LTD23.08%66
Sector Biopharmaceuticals
3SBio Inc. (ADR) : Connections
Tocagen, Inc.
Hong Kong Sansheng Ltd.
Shenzhen Sciprogen Bio-Pharmaceutical Co., Ltd.
Taizhou Huan Sheng Investment Management Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Collected Mind Ltd.
Zhejiang Sunshine Pharmaceutical Co., Ltd.
Liaoning Sunshine Science & Technology Development Co. Ltd.
Shanghai Aoxi Technology Information Consulting Co., Ltd.
Ample Harvest Investments Ltd.
Mudanjiang Youbo Pharmaceutical Co., Ltd.
Excel Partner Holdings Ltd.
UTStarcom, Inc.
Shenzhen Baishitong Technology Development Co., Ltd.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Liaoning Sunshine Bio-Pharmaceutical Co. Ltd.
Beingmate Group Co. Ltd.
Zyngenia, Inc.
CITIC Industrial Investment Group Corp. Ltd.
Shanghai Xingsheng Pharmaceutical Co., Ltd.
CFA Institute
The Multiple Myeloma Research Foundation, Inc.
Company contact information
3SBio, Inc.
Shenyang Economy & Tech Development
No. 3 A1, Road 10
Shenyang, Liaoning 110027

Phone : +86.24.25386000
Fax : +86.24.25811821
Web : www.3sbio.com
© 2017 People , Fundamentals and Ownership